Loading…

Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients

Objective: To investigate the role of HLA-B and HLA-DR genes as contributors to genetic susceptibility and clinical expression of the spondyloarthropathies (SpA) in the Mexican population. Methods: The study included 172 patients with SpA (undifferentiated SpA 83, ankylosing spondylitis (AS) 64, and...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the rheumatic diseases 2002-08, Vol.61 (8), p.714-717
Main Authors: Vargas-Alarcón, G, Londoño, J D, Hernández-Pacheco, G, Pacheco-Tena, C, Castillo, E, Cardiel, M H, Granados, J, Burgos-Vargas, R
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b610t-aabb5902283627c3d84c733c3896d872023952adf1da963365569eadaddd816b3
cites
container_end_page 717
container_issue 8
container_start_page 714
container_title Annals of the rheumatic diseases
container_volume 61
creator Vargas-Alarcón, G
Londoño, J D
Hernández-Pacheco, G
Pacheco-Tena, C
Castillo, E
Cardiel, M H
Granados, J
Burgos-Vargas, R
description Objective: To investigate the role of HLA-B and HLA-DR genes as contributors to genetic susceptibility and clinical expression of the spondyloarthropathies (SpA) in the Mexican population. Methods: The study included 172 patients with SpA (undifferentiated SpA 83, ankylosing spondylitis (AS) 64, and reactive arthritis 25) and 99 healthy controls. The HLA-B and HLA-DR alleles were detected by the polymerase chain reaction with sequence-specific primers technique. Patient assessment included demographic data, diagnostic categories, and disease patterns. Statistical methods included the Mantel-Haenzel χ2 test, Fisher's exact test, and Woolf method for odds ratio (OR). Differences of continuous variables between HLA allele groups were calculated by Student's t test. Results: Increased frequencies of HLA-B27 (pCh10−3, OR=28.7), HLA-DR1 (pC=0.045, OR=2.77), and HLA-B15 (p=0.034, pC=NS, OR=2.04) alleles in the whole group were found. HLA-B27 strength of association (OR) was 41.4 in AS; 20.9 in undifferentiated SpA; 27.2 in reactive arthritis. HLA-DR1 and HLA-B15 were increased in undifferentiated SpA (pC=0.045, OR=2.98 and p=0.004, pC=NS, OR=2.75). By analysing 58 HLA-B27 negative patients it was found that HLA-B15 and HLA-DR1 associations with SpA were independent of HLA-B27; increased frequencies of HLA-B15 were found in the whole SpA group and in patients with undifferentiated SpA (pC=0.03, OR=3.09 and pCh0.01, OR=3.77) and of HLA-DR1 in the latter (p=0.04, pC=NS, OR=3.15). HLA-B27 positive patients were younger than HLA-B27 negative patients at onset (p=0.03), but HLA-DR1 positive patients were older than HLA-DR1 negative patients (p=0.03). Bath indices for disease activity and functioning were higher in HLA-B27 positive patients (p=0.006 and p=0.004 v HLA-B27 negative patients). In contrast, neither HLA-DR1 nor HLA-B15 influenced these indices. Conclusion: Apart from HLA-B27, there is a significant association of HLA-DR1 and HLA-B15 with SpA in Mexicans which is independent of B27. HLA-B27 is associated with younger age at onset and increased disease severity and HLA-DR1 with older age at onset. The strength of HLA-B15, HLA-B27, and HLA-DR1 associations varied in different forms of SpA.
doi_str_mv 10.1136/ard.61.8.714
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1754177</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A90161585</galeid><sourcerecordid>A90161585</sourcerecordid><originalsourceid>FETCH-LOGICAL-b610t-aabb5902283627c3d84c733c3896d872023952adf1da963365569eadaddd816b3</originalsourceid><addsrcrecordid>eNp9klGPEyEQx4nReLX65rPZaNQXtzLLLrAvJrV3esaqF6PGN8IC21K3UGF7uX576bW5nqYxPMAMv_nPMAxCjwGPAAh9LYMeURjxEYPyDhpASXleYIrvogHGmORlTdkJehDjIpmYA7-PTqAAYJSxAfJnbWtUn_k2O5-O87eZdPr6dPo1mxlnYuZdFtdRmVVvG9vZfpP1_pqK5tKErZ1i48o7vem8DP08-JXs5zaFWpd9MldWSZcllzWujw_RvVZ20Tza70P0_d3Zt8l5Pv3y_sNkPM0bCrjPpWyaqsZFwQktmCKal4oRogivqeaswAWpq0LqFrSsKSG0qmhtpJZaaw60IUP0Zqe7WjdLo1XKHWQnVsEuZdgIL634-8bZuZj5SwGsKoGxJPBiLxD877WJvVja1IWuk874dRQMalyVdZHAZ_-AC78OLj0uaTHGy5JUJFFPd9RMdkZY1_qUVW0lxbjGQKHiVYJeHYG235Aq9M60Nrlv4_kRPC1tllYd4_fyKvgYg2lv2gFYbGdJpFkSFARPrysT_uR2Cw_wfngS8HwPyKhk1wbplI0HjjAOgItDnTb25urmXoZfgjLCKvH5x0TUp9XHn5OLixQ2RC93fLNc_L_EP7Xh6_U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777844353</pqid></control><display><type>article</type><title>Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients</title><source>PubMed (Medline)</source><creator>Vargas-Alarcón, G ; Londoño, J D ; Hernández-Pacheco, G ; Pacheco-Tena, C ; Castillo, E ; Cardiel, M H ; Granados, J ; Burgos-Vargas, R</creator><creatorcontrib>Vargas-Alarcón, G ; Londoño, J D ; Hernández-Pacheco, G ; Pacheco-Tena, C ; Castillo, E ; Cardiel, M H ; Granados, J ; Burgos-Vargas, R</creatorcontrib><description>Objective: To investigate the role of HLA-B and HLA-DR genes as contributors to genetic susceptibility and clinical expression of the spondyloarthropathies (SpA) in the Mexican population. Methods: The study included 172 patients with SpA (undifferentiated SpA 83, ankylosing spondylitis (AS) 64, and reactive arthritis 25) and 99 healthy controls. The HLA-B and HLA-DR alleles were detected by the polymerase chain reaction with sequence-specific primers technique. Patient assessment included demographic data, diagnostic categories, and disease patterns. Statistical methods included the Mantel-Haenzel χ2 test, Fisher's exact test, and Woolf method for odds ratio (OR). Differences of continuous variables between HLA allele groups were calculated by Student's t test. Results: Increased frequencies of HLA-B27 (pCh10−3, OR=28.7), HLA-DR1 (pC=0.045, OR=2.77), and HLA-B15 (p=0.034, pC=NS, OR=2.04) alleles in the whole group were found. HLA-B27 strength of association (OR) was 41.4 in AS; 20.9 in undifferentiated SpA; 27.2 in reactive arthritis. HLA-DR1 and HLA-B15 were increased in undifferentiated SpA (pC=0.045, OR=2.98 and p=0.004, pC=NS, OR=2.75). By analysing 58 HLA-B27 negative patients it was found that HLA-B15 and HLA-DR1 associations with SpA were independent of HLA-B27; increased frequencies of HLA-B15 were found in the whole SpA group and in patients with undifferentiated SpA (pC=0.03, OR=3.09 and pCh0.01, OR=3.77) and of HLA-DR1 in the latter (p=0.04, pC=NS, OR=3.15). HLA-B27 positive patients were younger than HLA-B27 negative patients at onset (p=0.03), but HLA-DR1 positive patients were older than HLA-DR1 negative patients (p=0.03). Bath indices for disease activity and functioning were higher in HLA-B27 positive patients (p=0.006 and p=0.004 v HLA-B27 negative patients). In contrast, neither HLA-DR1 nor HLA-B15 influenced these indices. Conclusion: Apart from HLA-B27, there is a significant association of HLA-DR1 and HLA-B15 with SpA in Mexicans which is independent of B27. HLA-B27 is associated with younger age at onset and increased disease severity and HLA-DR1 with older age at onset. The strength of HLA-B15, HLA-B27, and HLA-DR1 associations varied in different forms of SpA.</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/ard.61.8.714</identifier><identifier>PMID: 12117677</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><subject>Adult ; aetiological fraction ; Age of Onset ; ankylosing spondylitis ; BASDAI ; BASFI ; Bath Ankylosing Disease Activity Index ; Bath Ankylosing Spondylitis Functional Index ; Biological and medical sciences ; Confidence intervals ; Disease ; Disease susceptibility ; Diseases of the osteoarticular system ; Extended Report ; Female ; Gene Frequency ; Genes ; Genetic aspects ; Genetic Predisposition to Disease ; genetics ; Histocompatibility antigens ; HLA ; HLA histocompatibility antigens ; HLA-B Antigens - genetics ; HLA-B15 Antigen ; HLA-B27 Antigen - genetics ; HLA-DR1 Antigen - genetics ; Humans ; Inflammatory joint diseases ; major histocompatibility complex ; Male ; Medical sciences ; Mexican population ; Mexicans ; Mexico - ethnology ; MHC ; odds ratio ; ReA ; reactive arthritis ; SpA ; Spondylitis, Ankylosing - ethnology ; Spondylitis, Ankylosing - genetics ; Spondyloarthropathies ; Studies</subject><ispartof>Annals of the rheumatic diseases, 2002-08, Vol.61 (8), p.714-717</ispartof><rights>Copyright 2002 by Annals of the Rheumatic Diseases</rights><rights>2002 INIST-CNRS</rights><rights>COPYRIGHT 2002 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2002 Copyright 2002 by Annals of the Rheumatic Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b610t-aabb5902283627c3d84c733c3896d872023952adf1da963365569eadaddd816b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754177/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754177/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13781102$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12117677$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vargas-Alarcón, G</creatorcontrib><creatorcontrib>Londoño, J D</creatorcontrib><creatorcontrib>Hernández-Pacheco, G</creatorcontrib><creatorcontrib>Pacheco-Tena, C</creatorcontrib><creatorcontrib>Castillo, E</creatorcontrib><creatorcontrib>Cardiel, M H</creatorcontrib><creatorcontrib>Granados, J</creatorcontrib><creatorcontrib>Burgos-Vargas, R</creatorcontrib><title>Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Objective: To investigate the role of HLA-B and HLA-DR genes as contributors to genetic susceptibility and clinical expression of the spondyloarthropathies (SpA) in the Mexican population. Methods: The study included 172 patients with SpA (undifferentiated SpA 83, ankylosing spondylitis (AS) 64, and reactive arthritis 25) and 99 healthy controls. The HLA-B and HLA-DR alleles were detected by the polymerase chain reaction with sequence-specific primers technique. Patient assessment included demographic data, diagnostic categories, and disease patterns. Statistical methods included the Mantel-Haenzel χ2 test, Fisher's exact test, and Woolf method for odds ratio (OR). Differences of continuous variables between HLA allele groups were calculated by Student's t test. Results: Increased frequencies of HLA-B27 (pCh10−3, OR=28.7), HLA-DR1 (pC=0.045, OR=2.77), and HLA-B15 (p=0.034, pC=NS, OR=2.04) alleles in the whole group were found. HLA-B27 strength of association (OR) was 41.4 in AS; 20.9 in undifferentiated SpA; 27.2 in reactive arthritis. HLA-DR1 and HLA-B15 were increased in undifferentiated SpA (pC=0.045, OR=2.98 and p=0.004, pC=NS, OR=2.75). By analysing 58 HLA-B27 negative patients it was found that HLA-B15 and HLA-DR1 associations with SpA were independent of HLA-B27; increased frequencies of HLA-B15 were found in the whole SpA group and in patients with undifferentiated SpA (pC=0.03, OR=3.09 and pCh0.01, OR=3.77) and of HLA-DR1 in the latter (p=0.04, pC=NS, OR=3.15). HLA-B27 positive patients were younger than HLA-B27 negative patients at onset (p=0.03), but HLA-DR1 positive patients were older than HLA-DR1 negative patients (p=0.03). Bath indices for disease activity and functioning were higher in HLA-B27 positive patients (p=0.006 and p=0.004 v HLA-B27 negative patients). In contrast, neither HLA-DR1 nor HLA-B15 influenced these indices. Conclusion: Apart from HLA-B27, there is a significant association of HLA-DR1 and HLA-B15 with SpA in Mexicans which is independent of B27. HLA-B27 is associated with younger age at onset and increased disease severity and HLA-DR1 with older age at onset. The strength of HLA-B15, HLA-B27, and HLA-DR1 associations varied in different forms of SpA.</description><subject>Adult</subject><subject>aetiological fraction</subject><subject>Age of Onset</subject><subject>ankylosing spondylitis</subject><subject>BASDAI</subject><subject>BASFI</subject><subject>Bath Ankylosing Disease Activity Index</subject><subject>Bath Ankylosing Spondylitis Functional Index</subject><subject>Biological and medical sciences</subject><subject>Confidence intervals</subject><subject>Disease</subject><subject>Disease susceptibility</subject><subject>Diseases of the osteoarticular system</subject><subject>Extended Report</subject><subject>Female</subject><subject>Gene Frequency</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genetic Predisposition to Disease</subject><subject>genetics</subject><subject>Histocompatibility antigens</subject><subject>HLA</subject><subject>HLA histocompatibility antigens</subject><subject>HLA-B Antigens - genetics</subject><subject>HLA-B15 Antigen</subject><subject>HLA-B27 Antigen - genetics</subject><subject>HLA-DR1 Antigen - genetics</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>major histocompatibility complex</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mexican population</subject><subject>Mexicans</subject><subject>Mexico - ethnology</subject><subject>MHC</subject><subject>odds ratio</subject><subject>ReA</subject><subject>reactive arthritis</subject><subject>SpA</subject><subject>Spondylitis, Ankylosing - ethnology</subject><subject>Spondylitis, Ankylosing - genetics</subject><subject>Spondyloarthropathies</subject><subject>Studies</subject><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp9klGPEyEQx4nReLX65rPZaNQXtzLLLrAvJrV3esaqF6PGN8IC21K3UGF7uX576bW5nqYxPMAMv_nPMAxCjwGPAAh9LYMeURjxEYPyDhpASXleYIrvogHGmORlTdkJehDjIpmYA7-PTqAAYJSxAfJnbWtUn_k2O5-O87eZdPr6dPo1mxlnYuZdFtdRmVVvG9vZfpP1_pqK5tKErZ1i48o7vem8DP08-JXs5zaFWpd9MldWSZcllzWujw_RvVZ20Tza70P0_d3Zt8l5Pv3y_sNkPM0bCrjPpWyaqsZFwQktmCKal4oRogivqeaswAWpq0LqFrSsKSG0qmhtpJZaaw60IUP0Zqe7WjdLo1XKHWQnVsEuZdgIL634-8bZuZj5SwGsKoGxJPBiLxD877WJvVja1IWuk874dRQMalyVdZHAZ_-AC78OLj0uaTHGy5JUJFFPd9RMdkZY1_qUVW0lxbjGQKHiVYJeHYG235Aq9M60Nrlv4_kRPC1tllYd4_fyKvgYg2lv2gFYbGdJpFkSFARPrysT_uR2Cw_wfngS8HwPyKhk1wbplI0HjjAOgItDnTb25urmXoZfgjLCKvH5x0TUp9XHn5OLixQ2RC93fLNc_L_EP7Xh6_U</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>Vargas-Alarcón, G</creator><creator>Londoño, J D</creator><creator>Hernández-Pacheco, G</creator><creator>Pacheco-Tena, C</creator><creator>Castillo, E</creator><creator>Cardiel, M H</creator><creator>Granados, J</creator><creator>Burgos-Vargas, R</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>BMJ</general><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20020801</creationdate><title>Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients</title><author>Vargas-Alarcón, G ; Londoño, J D ; Hernández-Pacheco, G ; Pacheco-Tena, C ; Castillo, E ; Cardiel, M H ; Granados, J ; Burgos-Vargas, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b610t-aabb5902283627c3d84c733c3896d872023952adf1da963365569eadaddd816b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>aetiological fraction</topic><topic>Age of Onset</topic><topic>ankylosing spondylitis</topic><topic>BASDAI</topic><topic>BASFI</topic><topic>Bath Ankylosing Disease Activity Index</topic><topic>Bath Ankylosing Spondylitis Functional Index</topic><topic>Biological and medical sciences</topic><topic>Confidence intervals</topic><topic>Disease</topic><topic>Disease susceptibility</topic><topic>Diseases of the osteoarticular system</topic><topic>Extended Report</topic><topic>Female</topic><topic>Gene Frequency</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genetic Predisposition to Disease</topic><topic>genetics</topic><topic>Histocompatibility antigens</topic><topic>HLA</topic><topic>HLA histocompatibility antigens</topic><topic>HLA-B Antigens - genetics</topic><topic>HLA-B15 Antigen</topic><topic>HLA-B27 Antigen - genetics</topic><topic>HLA-DR1 Antigen - genetics</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>major histocompatibility complex</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mexican population</topic><topic>Mexicans</topic><topic>Mexico - ethnology</topic><topic>MHC</topic><topic>odds ratio</topic><topic>ReA</topic><topic>reactive arthritis</topic><topic>SpA</topic><topic>Spondylitis, Ankylosing - ethnology</topic><topic>Spondylitis, Ankylosing - genetics</topic><topic>Spondyloarthropathies</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vargas-Alarcón, G</creatorcontrib><creatorcontrib>Londoño, J D</creatorcontrib><creatorcontrib>Hernández-Pacheco, G</creatorcontrib><creatorcontrib>Pacheco-Tena, C</creatorcontrib><creatorcontrib>Castillo, E</creatorcontrib><creatorcontrib>Cardiel, M H</creatorcontrib><creatorcontrib>Granados, J</creatorcontrib><creatorcontrib>Burgos-Vargas, R</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vargas-Alarcón, G</au><au>Londoño, J D</au><au>Hernández-Pacheco, G</au><au>Pacheco-Tena, C</au><au>Castillo, E</au><au>Cardiel, M H</au><au>Granados, J</au><au>Burgos-Vargas, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>61</volume><issue>8</issue><spage>714</spage><epage>717</epage><pages>714-717</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Objective: To investigate the role of HLA-B and HLA-DR genes as contributors to genetic susceptibility and clinical expression of the spondyloarthropathies (SpA) in the Mexican population. Methods: The study included 172 patients with SpA (undifferentiated SpA 83, ankylosing spondylitis (AS) 64, and reactive arthritis 25) and 99 healthy controls. The HLA-B and HLA-DR alleles were detected by the polymerase chain reaction with sequence-specific primers technique. Patient assessment included demographic data, diagnostic categories, and disease patterns. Statistical methods included the Mantel-Haenzel χ2 test, Fisher's exact test, and Woolf method for odds ratio (OR). Differences of continuous variables between HLA allele groups were calculated by Student's t test. Results: Increased frequencies of HLA-B27 (pCh10−3, OR=28.7), HLA-DR1 (pC=0.045, OR=2.77), and HLA-B15 (p=0.034, pC=NS, OR=2.04) alleles in the whole group were found. HLA-B27 strength of association (OR) was 41.4 in AS; 20.9 in undifferentiated SpA; 27.2 in reactive arthritis. HLA-DR1 and HLA-B15 were increased in undifferentiated SpA (pC=0.045, OR=2.98 and p=0.004, pC=NS, OR=2.75). By analysing 58 HLA-B27 negative patients it was found that HLA-B15 and HLA-DR1 associations with SpA were independent of HLA-B27; increased frequencies of HLA-B15 were found in the whole SpA group and in patients with undifferentiated SpA (pC=0.03, OR=3.09 and pCh0.01, OR=3.77) and of HLA-DR1 in the latter (p=0.04, pC=NS, OR=3.15). HLA-B27 positive patients were younger than HLA-B27 negative patients at onset (p=0.03), but HLA-DR1 positive patients were older than HLA-DR1 negative patients (p=0.03). Bath indices for disease activity and functioning were higher in HLA-B27 positive patients (p=0.006 and p=0.004 v HLA-B27 negative patients). In contrast, neither HLA-DR1 nor HLA-B15 influenced these indices. Conclusion: Apart from HLA-B27, there is a significant association of HLA-DR1 and HLA-B15 with SpA in Mexicans which is independent of B27. HLA-B27 is associated with younger age at onset and increased disease severity and HLA-DR1 with older age at onset. The strength of HLA-B15, HLA-B27, and HLA-DR1 associations varied in different forms of SpA.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><pmid>12117677</pmid><doi>10.1136/ard.61.8.714</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2002-08, Vol.61 (8), p.714-717
issn 0003-4967
1468-2060
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1754177
source PubMed (Medline)
subjects Adult
aetiological fraction
Age of Onset
ankylosing spondylitis
BASDAI
BASFI
Bath Ankylosing Disease Activity Index
Bath Ankylosing Spondylitis Functional Index
Biological and medical sciences
Confidence intervals
Disease
Disease susceptibility
Diseases of the osteoarticular system
Extended Report
Female
Gene Frequency
Genes
Genetic aspects
Genetic Predisposition to Disease
genetics
Histocompatibility antigens
HLA
HLA histocompatibility antigens
HLA-B Antigens - genetics
HLA-B15 Antigen
HLA-B27 Antigen - genetics
HLA-DR1 Antigen - genetics
Humans
Inflammatory joint diseases
major histocompatibility complex
Male
Medical sciences
Mexican population
Mexicans
Mexico - ethnology
MHC
odds ratio
ReA
reactive arthritis
SpA
Spondylitis, Ankylosing - ethnology
Spondylitis, Ankylosing - genetics
Spondyloarthropathies
Studies
title Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A42%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20HLA-B%20and%20HLA-DR%20genes%20on%20susceptibility%20to%20and%20severity%20of%20spondyloarthropathies%20in%20Mexican%20patients&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Vargas-Alarc%C3%B3n,%20G&rft.date=2002-08-01&rft.volume=61&rft.issue=8&rft.spage=714&rft.epage=717&rft.pages=714-717&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/ard.61.8.714&rft_dat=%3Cgale_pubme%3EA90161585%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b610t-aabb5902283627c3d84c733c3896d872023952adf1da963365569eadaddd816b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1777844353&rft_id=info:pmid/12117677&rft_galeid=A90161585&rfr_iscdi=true